Rep. of Korea: Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
Rep. of Korea pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3002 Human blood | US$11.2 billion | 87.3% |
| 3004 Medicaments | US$1.1 billion | 8.4% |
| 3006 Pharmaceutical goods | US$229.7 million | 1.8% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$182.4 million | 1.4% |
| 3003 Medicaments | US$82.4 million | 0.6% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$54.1 million | 0.4% |
| Product | Value | Share |
|---|---|---|
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$10.5 billion | 82.2% |
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$800.7 million | 6.3% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$371.4 million | 2.9% |
| 300220 Vaccines: for human medicine | US$241.8 million | 1.9% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$130.1 million | 1.0% |
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$124.2 million | 1.0% |
| 300640 Pharmaceutical goods: dental cements and other dental fillings, bone reconstruction cements | US$106.4 million | 0.8% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$94.8 million | 0.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$88.3 million | 0.7% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$73.4 million | 0.6% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$4.8 billion | 52.0% |
| 3002 Human blood | US$3.7 billion | 40.3% |
| 3006 Pharmaceutical goods | US$298.7 million | 3.3% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$158.8 million | 1.7% |
| 3003 Medicaments | US$143.5 million | 1.6% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$104.6 million | 1.1% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$3.9 billion | 42.5% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$3.1 billion | 33.3% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$475.4 million | 5.2% |
| 300220 Vaccines: for human medicine | US$383.8 million | 4.2% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$162.8 million | 1.8% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$129.7 million | 1.4% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$122.5 million | 1.3% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$114.5 million | 1.2% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$96.5 million | 1.1% |
| 300190 Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | US$94.6 million | 1.0% |
Shares are of Rep. of Korea's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Rep. of Korea's trade.
More Rep. of Korea products
- 85 Electrical machinery and equipment and parts thereof
- 27 Mineral fuels, mineral oils and products of their distillation
- 87 Vehicles
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 39 Plastics and articles thereof
- 89 Ships, boats and floating structures
- 72 Iron and steel
- 29 Organic chemicals
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 26 Ores, slag and ash
- 33 Essential oils and resinoids
- 28 Inorganic chemicals
Rep. of Korea pharmaceutical products: questions and answers
How much pharmaceutical products does Rep. of Korea export?
In 2024, Rep. of Korea exported US$12.8 billion of pharmaceutical products (HS chapter 30), 1.7% of its total exports. That ranks it 18 of 213 exporting countries in the data.
What are Rep. of Korea's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Human blood (3002, US$11.2 billion), Medicaments (3004, US$1.1 billion), Pharmaceutical goods (3006, US$229.7 million).
How much pharmaceutical products does Rep. of Korea import?
In 2024, Rep. of Korea imported US$9.2 billion of pharmaceutical products (HS chapter 30), 1.5% of its total imports. That ranks it 20 of 226 importing countries in the data.
What are Rep. of Korea's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$4.8 billion), Human blood (3002, US$3.7 billion), Pharmaceutical goods (3006, US$298.7 million).
